BeOne Medicines AG (6160.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
BeOne Medicines AG
Address
Aeschengraben 27
Basel, MA 4051
Switzerland
Phone
41 61 685 19 00
Website
Sector
Healthcare
Industry
Biotechnology
Employees
11000
First IPO Date
August 08, 2018
Key Executives
| Name | Title | Pay | Year Born |
| John V. Oyler | Co-Founder, Executive Chairman & Chief Executive Officer | 23.07M | 1968 |
| Chan Lee | General Counsel, Senior VP & Corporate Secretary | 9.84M | 1968 |
| Aaron Rosenberg | Chief Financial Officer | 9.93M | 1977 |
| Wang Lai | President and Global Head of Research & Development | 10.34M | 1978 |
| Xiaodong Wang | Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | 33.31M | 1963 |
| Graham Hardiman | Global Head of Human Resources | 0 | N/A |
| Marcello Damiani | Chief Technology Officer | 0 | 1970 |
| Titus Ball | Vice President & Chief Accounting Officer | 0 | 1974 |
| Eleanor Duff | Senior Vice President & Head of Corporate Communications | 0 | N/A |
| Liza Heapes | Head of Investor Relations | 0 | N/A |
| Mark Lanasa | Senior Vice President & Chief Medical Officer for Solid Tumors | 0 | N/A |
AD
Description
BeiGene Ltd. is a global biotechnology enterprise, grounded in scientific research, committed to developing groundbreaking and economical pharmaceutical products. Its core mission is to enhance therapeutic outcomes and broaden patient access to critical medicines across the world. The company was co-founded by Xiao Dong Wang and John V. Oyler on October 28, 2010, and its corporate headquarters are situated in George Town, KY.
AD
